Palisade Bio (PALI) Amortizatization of Intangibles (2020 - 2021)
Palisade Bio's (PALI) quarterly Amortizatization of Intangibles came in at $5000.0 in Q4 2021, down 97.06% year-on-year from $170000.0 in Q4 2020, and down 96.18% on a QoQ basis from $131000.0 in Q3 2021.
Palisade Bio (PALI) Amortizatization of Intangibles (2020 - 2021) Analysis & Trends
Palisade Bio (PALI) has 2 years of Amortizatization of Intangibles data on file, last reported at $5000.0 in Q4 2021.
- On a quarterly basis, Amortizatization of Intangibles fell 97.06% year-over-year to $5000.0 in Q4 2021; TTM through Sep 2022 was $5000.0, a 99.8% decrease from a year earlier, with the FY2021 full-year figure at $2.3 million, up 1057.92% from the prior year.
- Amortizatization of Intangibles for Q4 2021 stood at $5000.0, down from $131000.0 in the prior quarter.
- Over the last five years, Amortizatization of Intangibles for PALI reached as high as $1.6 million in Q1 2021 and fell as low as $5000.0 in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | Palisade Bio | 424.57 Mn | 291.94 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 5,000.00 |
| Dec 31, 2021 | 5,000.00 |
| Sep 30, 2021 | 131,000.00 |
| Sep 30, 2021 | 131,000.00 |
| Jun 30, 2021 | 613,000.00 |
| Jun 30, 2021 | 613,000.00 |
| Mar 31, 2021 | 1.59 Mn |
| Mar 31, 2021 | 1.59 Mn |
| Dec 31, 2020 | 170,000.00 |
| Dec 31, 2020 | 170,000.00 |
| Sep 30, 2020 | 20,000.00 |
| Sep 30, 2020 | 20,000.00 |